Let's be realistic with the valuations. Everyone of the 3.7million people seeking treatment for Axillary Hyperhidrosis will want this drug, but to be conservative lets say only 3 million go for it.
3 million x 700 prescription price monthly = 2.1 billion.
That's $25 billion USD annually in revenue.
Let's say 70% profit after tax is 17 billion.
Then lets be conservative AGAIN and do a 15 PE = 264 billion MC USD
Thats = ~$170 USD SP, or $230 AUD
DO YOUR OWN RESRARCH GUYZ
Disclaimer: I am Cleary joking
Ann: Appointment of Dr Howie McKibbon as CEO, page-142
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.020(5.26%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $1.832M | 5.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 1023317 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 3589 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |